HMPL-013: all 109 studies that test it
Page 2 of 2. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT02976116Phase 2
- A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT02691299Phase 3
- A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] FruquintinibCompletedNCT02689752Phase 1
- A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT02590965Phase 2
- A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric CancerCompletedNCT02415023Phase 1/2
- A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)CompletedNCT02314819Phase 3
- A Phase Ib Study of Fruquintinib in 3rd Line mCRCCompletedNCT01975077Phase 1/2
- Food Effect Study of Single Dose of Fruquintinib (HMPL-013) in Healthy SubjectsCompletedNCT01955304Phase 1
- Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid TumorsCompletedNCT01645215Phase 1